Rein Therapeutics, Inc. (RNTX)
0.791
-0.01
(-1.12%)
USD |
NASDAQ |
Sep 21, 16:00
0.791
0.00 (0.00%)
After-Hours: 20:00
Rein Therapeutics Total Liabilities (Quarterly) : 10.77M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.77M |
| March 31, 2026 | 14.70M |
| December 31, 2025 | 9.467M |
| September 30, 2025 | 7.516M |
| June 30, 2025 | 9.466M |
| March 31, 2025 | 7.749M |
| December 31, 2024 | 14.85M |
| September 30, 2024 | 8.985M |
| June 30, 2024 | 8.379M |
| March 31, 2024 | 7.858M |
| December 31, 2023 | 20.99M |
| September 30, 2023 | 1.624M |
| June 30, 2023 | 1.197M |
| March 31, 2023 | 2.884M |
| December 31, 2022 | 3.384M |
| September 30, 2022 | 4.536M |
| June 30, 2022 | 5.151M |
| March 31, 2022 | 4.146M |
| December 31, 2021 | 4.577M |
| September 30, 2021 | 4.659M |
| June 30, 2021 | 4.401M |
| March 31, 2021 | 3.252M |
| December 31, 2020 | 4.179M |
| September 30, 2020 | 9.781M |
| June 30, 2020 | 9.471M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.60M |
| December 31, 2019 | 12.07M |
| September 30, 2019 | 11.14M |
| June 30, 2019 | 10.21M |
| March 31, 2019 | 9.552M |
| December 31, 2018 | 10.71M |
| September 30, 2018 | 12.10M |
| June 30, 2018 | 9.709M |
| March 31, 2018 | 4.856M |
| December 31, 2017 | 4.891M |
| September 30, 2017 | 5.023M |
| June 30, 2017 | 5.471M |
| March 31, 2017 | 2.875M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 2.578M |
| September 30, 2015 | 3.324M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 2.161M |
| September 30, 2014 | |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 65.97M |
| Shareholders Equity (Quarterly) | 55.20M |
| Current Ratio | 4.270 |